Month: January 2022

Molnupiravir Capsule

India is Going to Become a Center for Covid-19 Antiviral Drugs

After the drug controller issued emergency-use authorization to multiple pharmaceutical businesses in India to produce and commercialize generic versions of molnupiravir, India will become the world’s largest hub for Covid-19 antiviral general medication production. As Omicron infections develop in India, increased availability to molnupiravir will maintain hospitalizations and deaths to a manageable level. Dr. Reddy’s … Read more

You cannot copy content of this page